Literature DB >> 7780538

[Failure of the treatment with antibiotics in severe Salmonella infections in children and use of quinolones].

F Moulin1, J Raymond, M Bergeret, J L Iniguez, F Habib, M Chemillier-Truong, M A Legall, J Badoual, D Gendrel.   

Abstract

BACKGROUND: Quinolone antibiotics are effective in the treatment of Salmonella infections in adults. Their use in children is limited by their side-effects. POPULATION AND METHODS: Forty-two patients (21 girls and 21 boys), aged 1 month to 12 years (mean 3.3 yrs) were admitted from September 1991 to June 1993 for severe Salmonella infections. Criteria of severity were persistent diarrhea and fever for more than 3 days. Thirty-one of these patients were less than 5 years of age. Blood culture was positive in 7 out of 35 patients: culture of the stools was positive in all patients. Five of the 42 patients had presented an acute episode of Salmonella infection a few weeks earlier and had remained asymptomatic carriers until the new acute and severe episode of diarrhea. All patients were given usual antibiotics, mainly ampicillin, amoxicillin, trimethoprime-sulfamethoxazole. Twenty-five of these patients were then given pefloxacin, 12 mg/kg/day, since the 5th day, for 7 days, because persistence of diarrhea and fever.
RESULTS: Diarrhea and fever disappeared within less than 2 days in the group of patients given pefloxacin, even though in 6 patients the infecting Salmonella was in vitro resistant to beta-lactamins. Twenty % of patients remained asymptomatic carriers of Salmonella in the group treated by pefloxacin vs 47% in the group without it. There was no difference in species of Salmonella between both groups. None of the patients treated by pefloxacin developed side-effects during the six months following its administration.
CONCLUSIONS: Short treatment by pefloxacin may be an alternative choice for treating severe Salmonella infections in children.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780538     DOI: 10.1016/0929-693x(96)81152-3

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  1 in total

1.  Overcoming reduced antibiotic susceptibility in intracellular Salmonella enterica serovar Typhimurium using AR-12.

Authors:  M Shamim Hasan Zahid; Devika M Varma; Monica M Johnson; Antonio Landavazo; Eric M Bachelder; Bruce E Blough; Kristy M Ainslie
Journal:  FEMS Microbiol Lett       Date:  2021-06-16       Impact factor: 2.820

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.